Completed NA INTERVENTIONAL 2-arm NCT03582267

The Effect of Docosahexaenoic Acid Supplementation on Biomarkers of Concussion Over the Course of a Year in Canadian National Rugby Players

Sponsor: Texas Christian University

Interventions Docosahexaenoic Acid (DHA)

Updated 5 times since 2018 Last updated: Sep 12, 2019 Started: Aug 1, 2017 Primary completion: Aug 1, 2018 Completion: Aug 1, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Head Trauma and is currently completed. Texas Christian University leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Oct 2019 — Jan 2021 [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Aug 2018 — Oct 2019 [monthly]

Active Not Recruiting NA

First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Texas Christian University

Data source: Texas Christian University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Worth, United States